Tag Archives: Prevalence

Global Burden of Disease (Alzheimer’s Disease and Other Dementias, 1990-2016) Study: 2018 Update (Lancet Neurology)

Posted on December 15, 2018 by Dementia and Elderly Care News

Summary An update to the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study of 2016 has been published. The number of people living with dementia globally appears to have more than doubled between 1990 to 2016. “In the … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Quick Insights, Statistics, Systematic Reviews, Universal Interest | Tagged Age Standardised Death Rates, Age-Standardised Years of Life Lost (SYLL), Ageing Population, All-Cause Mortality, All-Cause Mortality and Cause-Specific Mortality for 249 Causes of Death (1980–2015), Alzheimer’s Disease: Prevalence, Amenable Mortality, Behavioural Risk Factors, Bill and Melinda Gates Foundation, DALYs, Dementia and Mortality, Dementia Prevention, Dementia Risk Factors, Diet High in Sugar-Sweetened Beverages, Disability Adjusted Life Years (DALY), Disease Burden, DisMod-MR 2.1 Model, Epidemiology, Epidemiology and Statistics, GBD 2016 Alzheimer’s Disease and Other Dementia Collaborators, Global Burden of Diseases Injuries and Risk Factors (GBD) Study, High Body-Mass Index (BMI), High Fasting Plasma Glucose, Lancet Neurology, Life Expectancy, Lifestyle Risk Factors, Modeling Causes of Death: Integrated Approach Using CODEm, Modifiable Risk Factors, Mortality, Prevalence, Prevalence of Cancer, Prevalence of Dementia, Prevention, Prevention Agenda, Prevention Programmes, Public Health, Risk Factors, Smoking, Social Epidemiology, Sugar- and Artificially Sweetened Beverages, Years Lost Due to Disability (YLD), Years of Life Lost (YLLs), YLDs | Leave a comment

Global Burden of Disease Study: 2016 Update (Lancet)

Posted on October 10, 2016 by Dementia and Elderly Care News

Summary This year’s update to the Global Burden of Disease Study again includes trends for Alzheimer’s Disease and other dementias, based on meta-analysis of prevalence studies. There was an increase of almost 40% in the total deaths from Alzheimer’s Disease … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, National, Quick Insights, Standards, Statistics, Systematic Reviews, UK, Universal Interest | Tagged Age Standardised Death Rates, Age-Standardised Years of Life Lost (SYLL), All-Cause Mortality, All-Cause Mortality and Cause-Specific Mortality for 249 Causes of Death (1980–2015), Alzheimer’s Disease: Prevalence, Amenable Mortality, Behavioural Risk Factors, Bill and Melinda Gates Foundation, Cause of Death Ensemble Model (CODEm), DALYs, Dementia and Mortality, Dementia Risk Factors, Disability-Adjusted Life Years (DALYs): Global Burden of Disease Study (2010), Disease Burden, Epidemiology, Epidemiology and Statistics, GATHER: Guidelines for Accurate and Transparent Health Estimates Reporting, GBD 2015, GBD 2015 Mortality and Causes of Death Collaborators, Global Burden of Disease 2015 Study, Global Burden of Disease Study (2015-6), Institute for Health Metrics and Evaluation: University of Washington, Kings College Hospital NHS Trust, Kings College London, Lancet, Life Expectancy, Lifestyle Risk Factors, London School of Hygiene and Tropical Medicine, Modifiable Risk Factors, Mortality, Mortality Morbidity and Wellbeing: Cancers, Mortality Morbidity and Wellbeing: Mental Health; Dementia; Long-Term Conditions and More, Mortality Rates, Mortality Risk Factors, Mortality Statistics, NCDs: Noncommunicable Diseases, Non-Communicable Diseases (NCD), Prevalence, Prevalence of Cancer, Prevalence of Dementia, Prevention, Prevention Programmes, Public Health, Risk Factors, Social Epidemiology, Years Lost Due to Disability (YLD), YLDs, YLLs | Leave a comment

World Alzheimer’s Day (BBC News / ARUK / OHE / NHS Choices)

Posted on September 22, 2015 by Dementia and Elderly Care News

Summary To mark World Alzheimer’s Day, life-expectancy and dementia incidence statistics, commissioned from the Office of Health Economics, have been used to arrive at the projection that perhaps one in three people born in the UK this year could develop … Continue reading →

Posted in Alzheimer’s Research UK, BBC News, Charitable Bodies, Commissioning, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Management of Condition, Models of Dementia Care, NHS Digital (Previously NHS Choices), Patient Care Pathway, Pharmacological Treatments, Quick Insights, Statistics, UK, Universal Interest | Tagged Accelerating Alzheimer's Research and Drug Development, Ageing Population, Ageing Society, Alzheimer’s Research UK (ARUK), ARUK: Alzheimer’s Research UK, Behind the Headlines, CFAS I Study, Cognitive Functioning and Ageing Study (CFAS), Costs of Dementia in UK, Delaying Onset: Cost Impact, Delaying Onset: Human Impact, Dementia Innovation, Dementia Research, Dementia Research Champions Group, Disease Modifying Treatment by 2025 (Aim), Disease Progression, Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, Dr Matthew Norton: Alzheimer's Research UK, Drug Development for Alzheimer's Disease, Drug-Development Pipeline, Epidemiology, Estimation of Future Cases of Dementia: From Males / Females Born in 2015, Forecasting Life Expectancy, Gender (Sex), Gender Differences in Diagnosis Rates, Incidence Studies, Life Expectancy, Life Table Data, Life Tables, National Life Tables, Office of Health Economics (OHE), OHE Consulting, OHE: Office of Health Economics, Prevalence, Prevalence of Dementia, Progression to Alzheimer's Disease, Slowing Progression: Cost Impact, Slowing Progression: Human Impact, Solanezumab (Eli Lilly), Trajectory of Dementia in the UK | Leave a comment

September 2015: World Alzheimer’s Month (ADI)

Posted on September 11, 2015 by Dementia and Elderly Care News

Summary September 2015 is the fourth global World Alzheimer’s Month™. This international awareness raising campaign, coordinated by Alzheimer’s Disease International (ADI), aims to raise awareness and challenge the stigma associated with dementia generally. The theme of World Alzheimer’s Month 2015 … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Charitable Bodies, For Carers (mostly), For Nurses and Therapists (mostly), In the News, International, Management of Condition, Models of Dementia Care, Patient Care Pathway, Patient Information, Person-Centred Care, Personalisation, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Ageing Population, Ageing Society, Alzheimer’s Disease International (ADI) Campaigns, Dementia Friends, Global Action Against Dementia, Global Context, Global Costs of Dementia, Global Dementia Framework, Global Health, Global Impact of Dementia: World Alzheimer Report 2015, Global Incidence of Dementia, Global Outlook, Global Prevalence of Dementia, Global Social Investment for Dementia, Incidence Studies, Prevalence, Prevalence of Dementia, World Alzheimer Report, World Alzheimer Report 2015, World Alzheimer's Month, World Alzheimer's Month 2015 (Remember Me), World Alzheimer's Month Posters, World Alzheimer’s Month 2015, World Alzheimers Day (ADI), Worldwide Costs of Dementia | Leave a comment

Global Impact of Dementia: World Alzheimer Report 2015 (Alzheimer’s Disease International)

Posted on August 27, 2015 by Dementia and Elderly Care News

Summary The World Alzheimer Report 2015, entitled “The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends” updates Alzheimer’s Disease International (ADI)’s global dementia statistics. This document reviews and analyses previous systematic reviews on the subject, and … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Charitable Bodies, Commissioning, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, International, Management of Condition, Models of Dementia Care, Quick Insights, Standards, Statistics, Systematic Reviews, UK, Universal Interest | Tagged ADI’s World Alzheimer Reports, Ageing Population, Ageing Society, Alzheimer’s Disease International (ADI), Cambridge Institute of Public Health, Cambridge Institute of Public Health: Cambridge University, Cambridge Institute of Public Health: University of Cambridge, Centre for Global Health Research: University of Edinburgh Medical School, Dementia Policy, Department of Neurobiology Care Sciences and Society: Karolinska Institutet, Epidemiology, Epidemiology and Statistics, First Global Ministerial Conference on Global Action Against Dementia, First Ministerial Conference on Global Action Against Dementia, First WHO Ministerial Conference on Global Action Against Dementia, First WHO Ministerial Conference on Global Action Against Dementia: Better Policies for People with Dementia, Global Action Against Dementia, Global Burden of Dementia, Global Context, Global Costs of Dementia, Global Dementia Framework, Global Health, Global Impact of Dementia: World Alzheimer Report 2015, Global Incidence of Dementia, Global Leadership, Global Ministerial Conference on Global Action Against Dementia (WHO), Global Observatory for Ageing and Dementia Care, Global Observatory for Ageing and Dementia Care: King’s College London, Global Outlook, Global Prevalence of Dementia, Global Social Investment for Dementia, Incidence Studies, Joint Action on Dementia, Karolinska Institute, Karolinska Institutet (Stockholm), Kings College London, Ministerial Conference on Global Action, Nossal Institute for Global Health: University of Melbourne, Peking University Health Science Center, Prevalence, Prevalence of Dementia, School of Public Health: Peking University Health Science Center, Systematic Reviews and Meta-Analyses, University of Cambridge, University of Edinburgh Medical School, University of Melbourne, World Alzheimer Report, World Alzheimer Report 2015, World Health Organization (WHO), World Health Organization’s First Ministerial Conference on Global Action Against Dementia, Worldwide Costs of Dementia | Leave a comment

Reducing Dementia Risk Factors: World Alzheimer Report 2014 (ADI / Department of Health / Dementia Challenge / World Dementia Council)

Posted on September 19, 2014 by Dementia and Elderly Care News

Summary Alzheimer’s Disease International (ADI) has published the World Alzheimer Report 2014, entitled “Dementia and Risk Reduction: An analysis of protective and modifiable factors” which examines the evidence on modifiable risk factors for dementia. It shows that dementia risks can … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Charitable Bodies, Commissioning, Community Care, Department of Health, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, International, Mental Health, Models of Dementia Care, National, Practical Advice, Public Health England, Quick Insights, Standards, Statistics, Systematic Reviews, UK, Universal Interest | Tagged 10/66 Dementia Research Group, 10/66 Dementia Research Group (ADI), Active and Healthy Ageing, ADI’s World Alzheimer Reports, Adipokines and Cytokines, Adiposity, Advanced Glycosylation End Products (AGEs), Agreeableness, Alcohol, Alcohol and Drug Consumption, Alcohol Concern, Alcohol Consumption, Alcohol Misuse, Alzheimer’s Disease International’s 10/66 Dementia Research Group, AlzRisk AD Epidemiology Database, Antihypertensive Drugs, Antioxidants, Anxiety Disorders and Dementia, APOE e4 Polymorphism, Ascertainment Bias, Atherosclerosis (Hardening of the Arteries), B Vitamins, B vitamins (Folate B6 and B12), Baltimore Longitudinal Study of Aging (BLSA), Biases in Epidemiological Studies of Dementia, Blackfriars Consensus Statement, Blackfriars Consensus [UK Health Forum website], Blackfriars Meeting Report (UK Health Forum), BMI: Body Mass Index, Body Mass Index (BMI), Brain Injury, Brain Pathology and Dementia Syndrome, Brain-Battering Hypothesis, Cardiovascular Risk, Cardiovascular Risk Factors, Cardiovascular Risk Factors (CVRF), Chicago Health and Aging Project (CHAP), Cholesterol, Cholesterol (Dyslipidaemia), Cholesterol Reduction, Cognitive Reserve, Cognitive Stimulation, Columbia University Medical Center, Conscientiousness, Cynical Distrust, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction, Dementia: a Public Health Priority, Dennis Gillings: Former World Dementia Envoy, Depression and Dementia, Developmental and Early-Life Risk Factors, Diabetes, Diet, Diet and Dementia, Dietary Factors, Early-Life Events, Eating and Drinking, EClipSE Collaborative, Education and Awareness, Education and Dementia, Education as Proxy Variable, Epidemiological Concepts, Epidemiology, Epidemiology and Statistics, European Dementia Prevention Initiative, Evidence for Risk Factors of Dementia, Extraversion, FINGER Trial in Finland (Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability), Finnish Cardiovascular Risk Factors Aging and Dementia (CAIDE), Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, Flavonoids, Folate, Framingham Heart Study, Global Observatory for Ageing and Dementia Care, Global Observatory for Ageing and Dementia Care: King’s College London, Glycaemic Control, Goteborg Longitudinal Population Study, Head Circumference, Health Service and Population Research Department: King’s College London, Healthy Lifestyles, High Density Lipoproteins (HDL), Hostility, Hypercholesterolaemia, Hyperhomocysteinaemia, Hyperinsulineamia, Hypertension, Improving Public Health, Incidence, Incidence of Alzheimer’s Disease, Increased Fat Intake, Information Bias, Insomnia, Institute of Education and Health Sciences at the Hospital Alemao Oswaldo Cruz, Integrated Approach to the Prevention of Dementia and Other Chronic Diseases, Kings College London, Leg Length, Life Course Approach, Life-Course Approach to Healthy and Active Ageing, Lifestyle, Lifestyle Risk Factors, Longitudinal Studies, Low Density Lipoproteins (LDL), Mediterranean Diet, Memory and Aging Project (MAP), Mental Health Service and Population Research Department: King's College London, Metabolic Syndrome, Midlife and Late-Life Hypertension, Midlife Hypertension, Midlife Obesity, Mild Traumatic Brain Injury, Minority Aging Research Study (MARS), Moderate Drinking, Modifiable Risk Factors, MRC Cognitive Function and Ageing Study (MRC CFAS), National Health and Nutrition Examination Survey (NHANES), Neuropathology, Neuroticism, Neuroticism Extraversion Openness Personality Inventory Revised (NEO-PI-R), Non-Communicable Diseases (NCD), Obesity, Obesity Risk, Obesity Time-Bomb, Observational Epidemiological Studies, Occupational Attainment, Omega-3 Fatty Acids, Openness (Personality Trait)), Overlapping Risk Factors, Participation Bias, Personality Traits Used in Dementia Epidemiologic Studies, Physical Activity, Physical Activity Programmes, Prevalence, Prevalence of Dementia, Preventable Dementia (Public Health England), Preventative Care, Preventative Services, Prevention, Prevention Agenda Linking Dementia and Other Non-Communicable Diseases, Prevention of Dementia, Prevention of Dementia: Public Health England, Prevention Programmes, Preventive Care, Preventive Services, Promoting Brain Health, Promoting Brain Health (Blackfriars Consensus Statement), Prospective Population Study of Women in Sweden, Psychological Distress: Personality and Life Events, Psychological Factors, Public Awareness, Public Health, Public Health Agenda, Public Health England (PHE), Public Health Programmes, Public Health Promotion, Public Health Promotion Campaigns, Raising Awareness, Reducing Health Inequalities, Reverse Causality, Risk Factors, Risk Factors for Alzheimer's Diseease, Risk Reduction: World Alzheimer Report 2014, Sedentary Behaviour, Sleep Disorders, Smoking, Statins, Summary of Evidence for Risk Factors of Dementia, Supporting Healthy Lifestyles, Survival Bias, Systemic Inflammation, Tobacco, Tobacco Consumption, Treatment of Diabetes, Type 2 Diabetes, Unhealthy Lifestyles, Universidade Federal de Sao Paulo, University of Geneva, USA Health and Retirement Survey, Use It or Lose It Hypothesis, Use of Statins, Vascular Risk Factors, Vitamin B12, Vitamin B6, Vitamin C, Vitamin E, Vitamins, WDC: World Dementia Council, World Alzheimer Report 2014, World Dementia Council, World Dementia Envoy | Leave a comment

Renewed Call for Parity of Esteem for Mental and Physical Health (BBC News / Department of Health)

Posted on September 9, 2014 by Dementia and Elderly Care News

Summary Professor Dame Sally Davies, England’s Chief Medical Officer, has expressed support for giving mental health services a higher priority, with targets for waiting times and better protection for funding. Mental illness is estimated to cost between £70bn and £100bn … Continue reading →

Tag Archives: Prevalence

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites